Zacks Investment Research on MSN
Barinthus Biotherapeutics PLC sponsored ADR (BRNS) upgraded to buy: What does it mean for the stock?
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward ...
Nexxen International Ltd. Sponsored ADR (NEXN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results